Key indicators: single-crystal X-ray study; T = 150 K; mean (C-C) = 0.002 Å; R factor = 0.046; wR factor = 0.107; data-to-parameter ratio = 20.0.
The title compound, C 21 H 17 N 3 O 3 , is a new polymorph of an already published structure [Shashidhar et al. (2006) . Acta Cryst. E62, o4473-o4475]. The previously reported structure crystallizes in the monoclinic space group C2/c, whereas the structure reported here is in the tetragonal space group I4 1 /a. The bond lengths and angles are similar in both structures. The molecule adopts an extended conformation via intramolecular N-HÁ Á ÁO and O-HÁ Á ÁN hydrogen bonds; the terminal phenyl ring and the hydroxylphenyl ring are twisted with respect to the central benzene ring by 44.43 (7) and 21.99 (8) , respectively. In the crystal, molecules are linked by N-HÁ Á ÁO hydrogen bonds, weak C-HÁ Á ÁO hydrogen bonds and weak C-HÁ Á Á interactions into a three-dimensional supramolecular network. 
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Cg1 is the centroid of the C1-C6 phenyl ring. Data collection: APEX2 (Bruker, 2013); cell refinement: SAINT (Bruker, 2013); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL2014 (Sheldrick, 2008) ; molecular graphics: DIAMOND (Brandenburg & Putz, 2012) ; software used to prepare material for publication: SHELXTL.
Manchester Metropolitan University, Tulane University and Erciyes University are acknowledged for supporting this study. In many reports, hydrazide-hydrazone compounds are considered to be good candidates for different pharmaceutical applications such as anti-bacterial (Bharti et al., 2010) , antifugal (Loncle et al., 2004) , antimicrobial (Garoufalias et al., 2002; Vicini et al., 2002) , anti-inflammatory (Sondhi et al., 2006) , anti-malarial and anti-tuberculotic activities (Kaymakçıoğlu & Rollas, 2002; Rahman et al., 2005) as well as anticonvulsant agents (Ragavendran et al., 2007; Çakır et al., 2001) . In addition, hydrazide-hydrazones were reported to elicit anti-cancer (Terzioglu & Gursoy, 2003) and anti-HIV properties (Vicini et al., 2009 ) and hence they have gained an important place in medicinal chemistry. As part of our study to obtain novel hydrazide-hydrazones with a wide spectrum of pharmaceutical properties we report herein the synthesis of the title compound as an example of a series of hydrazide-hydrazones.
The title compound, (I), is a tetragonal polymorph of the previously reported crystal structure which crystallizes in the monoclinic space group C2/c (Shashidhar et al., 2006) . The relative arrangement of the molecules in (I) is different from that previously reported.
The "extended" conformation of the title molecule (I) is largely determined by the intramolecular N-H···O and O-H···N hydrogen bonds (Table 1 and Fig. 1 ). The dihedral angle between the central 6-membered ring (C8-C13) and the phenyl ring (C1-C6) of the benzamide group is 44.43 (7)° while that with the phenol ring (C16-C21) is 21.99 (8)°. The molecular packing of (I) is stabilized by intermolecular N-H···O hydrogen bonds a weak C-H···π interaction (Table 1 and Fig. 2 ).
In 25 ml of ethanol, a mixture of 237 mg (1 mmol) 3-amino-2-phenylquinazolin-4(3H)-one, 122 mg (1 mmol) of salicaldehyde and a catalytic amount of glacial acetic acid was stirred and refluxed for 6hr. The mixture was cooled and the separated solid was recrystallized from ethanol to afford the pure product as pale-yellow crystals suitable for X-ray diffraction. m.p. 497 -501 K. ) is used only for calculating -R-factor-obs etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger. (7) −0.0153 (7) C4 0.0318 (7) 0.0340 (7) 0.0564 (10) −0.0049 (6) 0.0011 (7) 0.0010 (7 
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